Cardiovascular Therapies Targeting Left Atrial Appendage

Area of Science:

• Cardiology
• Medical Devices
• Stroke Prevention

Background:

• Atrial fibrillation (AF) poses a significant stroke risk.
• Left atrial appendage (LAA) closure offers an alternative to oral anticoagulation for stroke prevention in AF patients.
• Percutaneous and epicardial LAA closure devices have demonstrated safety and efficacy.

Purpose of the Study:

• To review the rationale and evidence supporting LAA closure.
• To discuss optimal patient and device selection criteria.
• To outline common challenges and complications associated with mechanical LAA exclusion.

Main Methods:

• Review of randomized clinical trials and registry data on LAA closure devices.
• Analysis of evidence for percutaneous and epicardial LAA closure techniques.
• Synthesis of current literature on LAA exclusion strategies.

Main Results:

• Strong evidence supports the safety and efficacy of percutaneous LAA closure.
• Epicardial LAA closure shows promise in reducing arrhythmia burden and improving homeostasis.
• Unresolved issues include optimal patient/device selection and management of complications like thrombus and leaks.

Conclusions:

• LAA closure is a viable stroke prevention strategy for select AF patients.
• Further research is needed to address optimal patient selection and management of procedural complications.
• Mechanical LAA exclusion requires careful consideration of risks and benefits.